The role of hematopoietic growth factors in the treatment of neoplastic diseases.
St Onge
J
J
Department of Medicine, Georgetown University Medical Center, Washington, DC 20007.
Jacobson
R J
RJ
D000740:Anemia / Q000209:etiology / Q000628:therapy; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007377:Interleukin-3 / Q000627:therapeutic use; D016173:Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D010257:Paraneoplastic Syndromes / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use
D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D007377:Interleukin-3; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016173:Macrophage Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor